Mirae Asset Global Investments’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.55K | Buy |
8,450
+1,434
| +20% | +$1.62K | ﹤0.01% | 1498 |
|
|
2025
Q1 | $10.9K | Buy |
7,016
+29
| +0.4% | +$45 | ﹤0.01% | 1457 |
|
|
2024
Q4 | $15.3K | Sell |
6,987
-576
| -8% | -$1.26K | ﹤0.01% | 1458 |
|
|
2024
Q3 | $22K | Buy |
7,563
+1,330
| +21% | +$3.87K | ﹤0.01% | 1418 |
|
|
2024
Q2 | $15.2K | Sell |
6,233
-355,680
| -98% | -$868K | ﹤0.01% | 1423 |
|
|
2024
Q1 | $1.77M | Buy |
361,913
+166,433
| +85% | +$813K | ﹤0.01% | 1260 |
|
|
2023
Q4 | $627K | Sell |
195,480
-233,013
| -54% | -$748K | ﹤0.01% | 1858 |
|
|
2023
Q3 | $1.36M | Buy |
428,493
+32,770
| +8% | +$104K | ﹤0.01% | 1377 |
|
|
2023
Q2 | $1.96M | Buy |
395,723
+30,749
| +8% | +$152K | ﹤0.01% | 1226 |
|
|
2023
Q1 | $1.8M | Buy |
364,974
+28,305
| +8% | +$140K | ﹤0.01% | 1264 |
|
|
2022
Q4 | $2.12M | Sell |
336,669
-48,592
| -13% | -$306K | 0.01% | 1115 |
|
|
2022
Q3 | $4.16M | Buy |
385,261
+59,065
| +18% | +$638K | 0.01% | 870 |
|
|
2022
Q2 | $3.72M | Buy |
326,196
+112,565
| +53% | +$1.28M | 0.01% | 929 |
|
|
2022
Q1 | $1.95M | Sell |
213,631
-38,829
| -15% | -$354K | ﹤0.01% | 1162 |
|
|
2021
Q4 | $3.77M | Buy |
252,460
+36,378
| +17% | +$543K | 0.01% | 958 |
|
|
2021
Q3 | $5.55M | Buy |
216,082
+42,628
| +25% | +$1.1M | 0.01% | 817 |
|
|
2021
Q2 | $4.52M | Buy |
173,454
+17,401
| +11% | +$454K | 0.01% | 840 |
|
|
2021
Q1 | $5.51M | Buy |
156,053
+70,127
| +82% | +$2.48M | 0.02% | 714 |
|
|
2020
Q4 | $2.17M | Buy |
85,926
+34,517
| +67% | +$871K | 0.01% | 894 |
|
|
2020
Q3 | $1.94M | Buy |
51,409
+16,121
| +46% | +$608K | 0.01% | 787 |
|
|
2020
Q2 | $1.51M | Buy |
+35,288
| New | +$1.51M | 0.01% | 774 |
|